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Pathology of the axon–myelin unit in 
multiple sclerosis (MS)
Immune cells enter the peripheral nervous system (PNS) and 
central nervous system (CNS) in several neurological condi-
tions of infectious or autoimmune origin. These immune invad-
ers interact with the target tissue, which can result in damage of 
neural cells. The predominant resident target is often used to 
classify the resulting disease: for instance, myelin and axons are 
targeted in the case of demyelinating and axonal polyneuropa-
thies, respectively (Köller et al., 2005; Kuwabara and Yuki, 2013). 
Yet, on biopsy, many demyelinating polyneuropathies present 
with mixed myelin and axon pathology (Bosboom et al., 2001), 
with the latter serving as an important predictor of disease out-
come (Bouchard et al., 1999). The intertwined nature of axon 
and myelin pathology becomes even more apparent in MS, a 
common inflammatory disease of the CNS. MS has been classi-
cally regarded as a primarily demyelinating disorder. However, 
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recent work indicates that axon injury is already prominent in 
the earliest stages of MS (Trapp et al., 1998; Kuhlmann et al., 
2002; Singh et al., 2013). The finding that damage can be initi-
ated in axons that are still myelinated, both in experimental and 
human neuroinflammatory lesions (Nikić et al., 2011), further 
indicates that axons can—at least in some cases—be a primary 
target of the inflammatory attack. Hence, primary and second-
ary immune targets are difficult to differentiate with certainty. 
This is even more accentuated in progressive MS, which is 
characterized by a spread of neurodegeneration into both gray 
and white matter (Lassmann et al., 2012) and the parallel expan-
sion of myelin damage, leading to confluent areas of subpial de-
myelination in the cortices of progressive MS patients (Bø et al., 
2003; Kutzelnigg et al., 2005). Overall, the neuroglial conun-
drum is best illustrated by the fact that neuronal, and not glial 
damage, is the best predictor of long-term outcome, even if de-
myelination is the most prominent histopathological feature of 
the MS lesion (Bjartmar et al., 2000; De Stefano et al., 2001; 
Lubetzki and Stankoff, 2014). Together, these findings indicate 
that neuronal and glial pathology in inflammatory conditions 
should not be regarded as separate entities but rather as highly 
interdependent entry points into damage of a common target, 
the axon–myelin unit.
In this review, we bring together findings from the fields 
of axon and myelin biology to develop an integrated view of 
neuroinflammatory axon–myelin pathology. In particular, we 
discuss the commonalities and differences in the way axons and 
glial cells degenerate to find out which mechanistic concepts 
can be transferred from one cell type to the other. We further 
explore the interdependence of axons and myelin to better un-
derstand how glial dysfunction might cause axonal damage and 
vice versa. Finally, we suggest that the special geometry and 
spatial relation of axons and oligodendrocytes help to explain 
the spreading of pathology in advanced stages of MS.
Demyelination and axon loss are pathological hall-
marks of the neuroinflammatory disorder multiple scle-
rosis (MS). Although we have an increasingly detailed 
understanding of how immune cells can damage axons 
and myelin individually, we lack a unified view of how 
the axon–myelin unit as a whole is affected by immune- 
mediated attack. In this review, we propose that as a re-
sult of the tight cell biological interconnection of axons 
and myelin, damage to either can spread, which might 
convert a local inflammatory disease process early in 
MS into the global progressive disorder seen during 
later stages. This mode of spreading could also apply 
to other neurological disorders.
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unlikely that nodes of Ranvier harbor all essential surface mol-
ecules, such as transporters and ion channels, that are required 
for maintaining axonal integrity and communication with the 
extracellular environment. Instead, communication may occur 
in part via myelinating oligodendrocytes. Indeed, oligodendro-
cytes provide nutritional support (by virtue of lactate transport) 
to associated axons (Fünfschilling et al., 2012; Lee et al., 2012). 
In addition, glia-derived exosomes have been recently shown 
to participate in a novel mode of neuron–glia communication 
(Frühbeis et al., 2013). This on-demand supply of glial support 
nicely illustrates the close functional coupling of glia and axons, 
which is essential for proper function of the axon–myelin unit.
Cellular mechanisms of axon degeneration
More than for most other cells, geometry matters to neurons—
the right number, length, and shape of axons, dendrites, and syn-
apses all are important for neuronal function. As a consequence, 
neuronal damage is a complex process. It can start at different 
sites and comes in morphologically and mechanistically differ-
ent flavors (Coleman et al., 2005). This has long been known by 
neuropathologists and is reflected in the commonly used classi-
fication of axon loss as either following a pattern of (Wallerian) 
degeneration, a fast fragmentation process that is presumably 
initiated at the cut site in the axon and spreads centrifugally, or a 
pattern of dying-back pathology, which is generally considered 
to start at the synapse and involves the slow centripetal retrac-
tion of the axon (Fig. 2 A; Luo and O’Leary, 2005). Beyond these 
classical categories, other more focal forms of compartmental-
ized neurite loss have been described, ranging from synaptosis 
(Gillingwater and Ribchester, 2001) to spontaneous pruning of 
axon branches (Martin et al., 2010) and localized axosome shed-
ding (Bishop et al., 2004). Before considering the relation of the 
distinct patterns of axon loss to neuroinflammatory disease pro-
cesses, we would like to briefly outline the current knowledge 
of the mechanism underlying axon loss (for a detailed review 
of the molecular mechanisms, see, e.g., Coleman and Freeman, 
2010; Wang et al., 2012).
Wallerian degeneration (Fig. 2 A, left) is undoubtedly the 
most thoroughly investigated form of axon loss—and indeed, 
ongoing research is revealing the molecular pathways that re-
sult in the removal of severed axon segments. The starting point 
for this mechanistic deconstruction of Wallerian axon disman-
tling has been the serendipitous identification of a spontaneous 
mouse mutant with profoundly delayed Wallerian degeneration 
(WLDS [Wallerian degeneration slow]; Lunn et al., 1989). 
Molecular genetic analysis of this mutant has resulted in the sur-
prising identification of enzymes of the NAD biosynthetic path-
way as central players in axon degeneration (Coleman et al., 1998; 
Conforti et al., 2000), even though the details of the underlying 
molecular mechanisms that actually result in axon fragmentation 
remain to be elucidated. Importantly, the phylogenetic conserva-
tion of WLDS sensitivity has allowed identification of Wallerian-
like degeneration events in “screenable” organisms, such as 
Drosophila melanogaster (Hoopfer et al., 2006; MacDonald et al., 
2006). This has paved the way for new investigations that have 
identified additional components of endogenous axon-dismantling 
pathways, such as dual leucine zipper kinase–Wallenda (Miller 
Cell biology of the axon–myelin unit
One of the most striking features of the axon–myelin unit is 
the close association of two plasma membrane surfaces over 
extensive areas. In general, plasma membrane interactions are 
prevented by repulsive forces generated by steric and electro-
static repulsion of large and negatively charged oligosaccharide 
polymers present at the cell surface. In most cases, membranes 
are, therefore, only closely connected to each other within tiny 
regions by anchoring junctions that are strong enough to overcome 
the repellent forces of the cell surface. The advantage of this 
general arrangement is that the majority of the plasma mem-
brane surface remains exposed to the extracellular space and 
diffusible signals, whereas cell–cell interactions are confined to 
specialized signaling hubs. Axons in contrast, require a special 
arrangement of their membrane surface to allow the fast salta-
tory conduction of action potentials. Whereas saltatory conduc-
tion avoids the need to constantly regenerate the impulses along 
the axonal surface, it comes at a price. First, the axon becomes 
dependent on oligodendrocytes for communication with the 
external environment. Thus, the axon is not only electrically 
but also metabolically isolated (Nave, 2010). Second, there is 
a massive redistribution of proteins from the internodal mem-
brane toward the nodes of Ranvier, which are small (1 µm) 
myelin-free gaps on the axonal surface between two neighbor-
ing internodes that remain in contact with extracellular space. 
Because this particular molecular composition of the nodal re-
gion is likely of major relevance for the emergence of axon– 
myelin pathology, we briefly summarize some of its key features.
When myelin sheath biogenesis is completed, the firmly 
attached lateral edges of the myelin layers come closely to-
gether to form the paranodal loops (Fig. 1). These form septate 
junctions with the axonal surface, held together by the adhe-
sion proteins Caspr and contactin on the axonal side and neu-
rofascin-155 on the glial surface (Fig. 1; Salzer et al., 2008). 
Paranodes are further strengthened by a submembranous cyto-
skeleton consisting of ankyrinB, II-spectrin, and II-spectrin 
(Zhang et al., 2013). Juxtaparanodal junctions, which include a 
complex formed by TAG-1 on the glial surface and Caspr2 on 
the axonal side (Traka et al., 2003), further help to maintain the 
domain structure at the nodes and the flanking juxtaparanodes. 
Within the limited space of a node of Ranvier, large multimolecu-
lar complexes are formed consisting of sodium channels, cell 
adhesion molecules (neurofascin-186), cytoskeleton proteins 
(IV-spectrin), scaffolding proteins (ankyrinG), and extracel-
lular matrix proteins (brevican, versican, and Bral1; Sherman 
et al., 2005; Feinberg et al., 2010; Susuki et al., 2013). In addition 
to sodium channels, specific types of voltage-gated K+ channels 
(KCNQ2 and KCNQ3) also localize to the nodes. Such a dense 
concentration of molecules, which among other functions main-
tain structural integrity and mediate ion fluxes, onto relatively small 
areas at the cell surface might also carry a substantial risk and 
predispose the nodes of Ranvier as “hot spots” for the initiation 
of axonal damage (Arancibia-Carcamo and Attwell, 2014).
A large amount of the axonal membrane in the internodal 
region (i.e., between the two paranodal domains) is not in direct 
contact with the extracellular environment but faces the insulat-
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are related to the enzyme mutated in WLDS mice, Nmnat2 has 
the shortest lifetime and is associated with motile vesicles, sug-
gesting that its continuous supply acts as a tonic endogenous 
survival signal for axons. This transport model provides a con-
ceptual framework for the observed lag phase and explains why 
disruption of microtubule transport can substitute for transec-
tion as the trigger for Wallerian degeneration. Although the 
transport hypothesis is attractive, other explanations obviously 
exist—for example, the emergence of positive destruction sig-
nals, which could be as simple as an increasing load of ions 
that may activate self-destruction via bioenergetic deprivation 
(Mishra et al., 2013).
In contrast to Wallerian degeneration, which is typically 
initiated in the axonal compartment, the centripetal spread from 
the synapses (Fig. 2 A, center) is part of the defining criteria of 
die back; however, many other mechanistic aspects of this wide-
spread pattern of axon loss remain obscure. In classical patho-
logical parlance, die back suggests a mechanism in which the 
most distal structures would be deprived of a shared resource 
(Schaumburg et al., 1974). Die-back patterns of axon loss have 
been described prominently in toxic and degenerative forms 
of axon loss (Fischer et al., 2004; Schaefer et al., 2005). 
In these disease processes, distal axonal segments disappear 
et al., 2009), ZNRF1 (Wakatsuki et al., 2011), sterile  motif–
containing and armadillo motif–containing protein (Sarm1; 
Osterloh et al., 2012), and the E3 ubiquitin ligase Phr1 (Xiong 
et al., 2012; Babetto et al., 2013), the abolition of which results 
in a WLDS-like phenotype. Although the molecular principles of 
Wallerian degeneration are emerging, some of the characteristic 
cell biological features of Wallerian degeneration remain to be 
explained. These include the lag phase, a characteristic property 
of Wallerian degeneration that precedes onset of fragmentation 
after axon transection (Vargas and Barres, 2007). The signifi-
cance and cause of this lag is not yet fully understood—for in-
stance, synaptic versus axonal compartments seem to differ in 
this respect for unexplained reasons (Gillingwater and Ribchester, 
2003). Perhaps the most prevailing explanation is the idea of 
an axon-intrinsic default destruction mechanism (Raff et al., 
2002). This view is obviously inspired by models of cellular 
suicide and surmises that distal axon segments contain destruc-
tive machinery that is held at bay by a continuous supply of in-
hibitory factors provided through axonal transport. This model 
predates identification of the WLDS mutation (Lubińska, 1982), 
which provides an obvious set of potential protectors. Indeed, 
Gilley and Coleman (2010) have shown that among the three 
murine nicotinamide mononucleotide adenylyl transferases that 
Figure 1. Molecular composition of the axon–myelin unit. Schematic diagram and electron microscopy images showing the different domains of a my-
elinated axon. Each of these domains is characterized by the expression of specific proteins: the node of Ranvier contains voltage-gated Na+ channels 
(NaCh), the paranode is the region where myelin is tightly attached to the axon by a complex formed by neurofascin-155 (NF155), contactin-1 (Cntn1), 
and contactin-associated protein (Caspr1), and the juxtaparanode where most voltage-gated K+ channels (KCh) are found is separated from the paranodes 
by a complex formed by contactin-associated protein 2 (Caspr2) and contactin-2 (Cntn2). The internodal region contains several cell adhesion molecules 
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this results in a genuine dying-back pattern or early synapse loss. 
Indeed, our own recent work suggests that nonclassical axon 
loss mechanisms might be at work, which are less global than 
either Wallerian degeneration or a dying-back type of dystrophy. 
Our in vivo observations in murine MS models have revealed 
the focal emergence of swellings that are predilection sites for 
subsequent axon breakage (Nikić et al., 2011). This form of 
focal axonal degeneration (Fig. 2 A, right) does not conform 
to the morphological and dynamic characteristics that we have 
previously observed in the same axon population during Walle-
rian degeneration and Wallerian-like acute axonal degeneration 
after trauma (Kerschensteiner et al., 2005) and, hence, is likely 
distinct in molecular terms (albeit this still has to be formally 
proven). Interestingly, focal axonal degeneration seems to pref-
erentially emerge at nodes of Ranvier but, at the same time, does 
not seem to be promoted by demyelination (Nikić et al., 2011), 
suggesting that it is the special metabolic demand on nodes, 
rather than their lack of a myelin sheath, that renders this site 
susceptible. Importantly, demise is not an invariable outcome for 
these predamaged axons, as the focal axonal degeneration cas-
cade seems to be reversible even in relatively advanced stages of 
morphological, subcellular, and functional disruption. Thus, the 
somewhat surprising identification of a subacute form of axon 
loss that appears to be dependent on inflammation, but not on 
demyelination, begs a more detailed discussion of how oligo-
dendrocyte and axon pathology might intersect in the human 
disease, such as MS, in which both are dominant features.
Mechanisms of oligodendrocyte degeneration
Oligodendrocyte injury can occur by a diverse range of insults, 
among which inflammation ranks prominently. Given the ge-
ometry of the oligodendrocyte, the consequences of damage 
not only depend on the nature of the attack but also on the site 
where oligodendrocytes are targeted. If sufficiently strong injury 
occurs at the level of the cell body, pathology is likely to spread 
centrifugally to all myelin segments that are connected to the 
oligodendrocyte (Fig. 2 B). Depending on the brain region, the 
consequences can be dramatic: whereas some oligodendrocytes 
in the spinal cord generate myelin only around one large axon, 
a single cell in the cortex and corpus callosum can myelinate 
≤80 internodes (Chong et al., 2012). This suggests that injury 
could radiate out substantially, but to understand how fast such 
spread might occur, we need to know how long myelin inter-
nodes are able to survive without being connected to an oligo-
dendrocyte. Recently, using in vivo pulse–chase labeling of 
proteins synthesis with 15N isotopes, followed by mass spec-
trometry, myelin proteins were found to be among the longest 
lived proteins in the mouse (Toyama et al., 2013). Considering 
that myelin is, in contrast to most membranes, a highly stable 
system, which is close to equilibrium at steady state (Aggarwal 
et al., 2011), it is possible that myelin internodes can continue 
to exist for a long time without being associated with an oligo-
dendrocyte. Although we know only little about the relative ki-
netics of oligodendrocyte and myelin injury, some clues have 
come from oligodendrocyte ablation experiments (Traka et al., 
2010; Ghosh et al., 2011; Pohl et al., 2011; Locatelli et al., 
2012; Oluich et al., 2012). When the diphtheria toxin receptor is 
first, whereas proximal axons and somata are relatively spared. 
A progressive retrograde spread of pathology is then believed to 
result in progressive denervation and eventually neuronal cell 
death. As most (but not all; compared with toxic sensory neu-
ropathies) axons bear synapses at their distal-most tips, early 
synaptic loss is often equated with a dying-back pattern of axon 
loss. Given the geometry of this form of axon loss and the fact 
that cytoskeleton-disrupting drugs can induce a dying-back pat-
tern, axonal transport is believed to also play a central role in 
this form of axon loss. In contrast to Wallerian degeneration, 
such transport deficits would be more subtle and chronic—and 
the relevant cargoes remain unidentified.
Although Wallerian degeneration and dying back repre-
sent the best-characterized forms of axon loss, other patterns 
exist—some resemble Wallerian degeneration (e.g., the devel-
opmental pruning of long spinal axons, which appears to in-
volve fragmentation but is not blocked efficiently by WLDS; 
Hoopfer et al., 2006), whereas others look like axonal die back 
(the distal-to-proximal shedding of axonal particles seen dur-
ing developmental branch loss in the PNS; Bishop et al., 2004). 
Others, however, seem to differ entirely—and these might be 
the most relevant forms of axon loss for inflammation-mediated 
CNS injury. Indeed, the role of Wallerian-like mechanisms in 
MS and its animal models remains unclear (Coleman et al., 
2005), in part because the WLDS mutation might also have 
effects on nonneural cells (Kaneko et al., 2006; Chitnis et al., 
2007; Dziedzic et al., 2010). Hence, even though disconnected 
axon fragments undoubtedly undergo Wallerian degeneration 
also in neuroinflammation (Dziedzic et al., 2010), WLDS-mediated 
protection against inflammatory axon damage appears to be 
hard to prove. Similarly, although chronic axonal dystrophy 
seems likely to occur in advanced stages of MS (Schirmer et al., 
2011; Lassmann et al., 2012), it is not fully resolved, whether 
Figure 2. Patterns of axon and myelin injury. (A, left) Axonal damage can 
either follow a classical centrifugal Wallerian pattern emanating from the 
cell body or an axonal transection. (middle) In contrast, an axonal die-back 
pattern originates at or near the synaptic compartment and spreads cen-
tripetally. (right) Finally, focal forms of axon injury have been described, 
e.g., during neuroinflammatory attack. (B) Similarly, in oligodendrocytes, 
injury can start at the soma (left), at the myelin sheaths (oligodendrocytic 










Published August 4, 2014
339Cell biological perspective on axon–myelin injury • Simons et al.
head group of phosphoinositol 4,5-bisphosphate and phosphati-
dylserine in the lipid bilayer (Musse et al., 2008; Nawaz et al., 
2009). Even disturbing local ionic strength (other than calcium) 
and pH may be sufficient to reduce the adhesion of MBP to the 
myelin lamellae and thereby decrease myelin stability.
Myelin damage does not only occur from the outside of 
the sheath but can also start at the innermost tongue of myelin. 
This form of oligodendrocyte cell death has been termed dying-
back oligodendropathy, as it is initiated in the most distal area 
of the cell and spreads retrogradely. The first evidence for such 
a process came from mice fed with cuprizone (a copper chela-
tor), in which degenerative changes were first observed in the 
inner tongue of the myelin sheath that extended back to the cell 
body 3–4 wk later (Ludwin and Johnson, 1981). Similar altera-
tions have been detected in some brain biopsies of MS patients 
and in Theiler’s virus–induced encephalomyelitis (Rodriguez, 
1992). The molecular changes underlying dying-back oligoden-
dropathy have so far remained obscure. Recent analyses using 
high-pressure freezing electron microscopy have shown that the 
region of the myelin sheath close to the axonal surface is filled 
with organelles and appears to be metabolically more active 
than previously thought (Möbius et al., 2010; Snaidero et al., 2014). 
Much like the synapses of an axon, the innermost tongue of 
myelin might thus be particularly vulnerable to metabolic dis-
turbances, possibly because of its high energy demand and its 
long distance from the cell body. An alternative possibility is 
that disruptions of adhesions between the inner tongue and the 
axon could trigger a pathology that subsequently spreads back-
ward. Evidence for such a scenario comes from aged mice defi-
cient for the adhesion molecule myelin-associated glycoprotein, 
which show the first signs of damage within the periaxonal 
inner tongue reminiscent of a dying-back oligodendropathy 
(Lassmann et al., 1997; Weiss et al., 2000).
The axon–myelin unit as a target of 
inflammatory attack
To understand axonal pathology in demyelinating disease, it is 
important to look at myelin and the underlying axon as a closely 
connected functional unit and ask how damage of one component 
affects survival and well-being of the other. Large-scale loss of 
the insulating function of myelin results in a drop of nerve con-
duction speed and possibly conduction block. To compensate, 
demyelinated axons start to express Na+ channels along the entire 
axon. However, these changes come at the cost of increased en-
ergy demand to maintain ion gradients. Considering the already 
high energy expenditure of a neuron, which has been estimated 
to be approximately five billion ATP molecules per second in a 
cortical neuron (Zhu et al., 2012), it is likely that loss of myelin 
pushes the energy requirement of a neuron to an upper limit. 
This situation has been termed virtual hypoxia, which stands for 
a mismatch of energy demand and supply eventually leading to 
axon damage (Stys, 2005; Trapp and Stys, 2009). According to 
this model, the ATP supply of denuded axons is not sufficient for 
efficiently operating Na+/K+-ATPase pumps and hence to clear 
the increased axonal Na+ load. If Na+ rises above a critical con-
centration, the Na+/Ca2+-ATPase will start to operate in reverse 
mode, which leads to accumulation of intra-axonal Ca2+ and the 
targeted to oligodendrocytes in transgenic mice, the subsequent 
injection of diphtheria toxin, which acts as an RNA translation 
inhibitor, allows specific ablation of oligodendrocytes. The first 
signs of cell death are found 1 wk after the toxin injection, 
when the cell bodies appear damaged with shrunken nuclei and 
condensed cytoplasm. Myelin vacuolization (i.e., the loss of the 
typical dense packing of myelin layers) starts only about 3 wk 
after injection, and fully demyelinated axons are seen after 
another 2 wk, confirming that myelin might be rather long lived 
even if oligodendrocyte viability is compromised. Such a cen-
trifugal or “inside-out” pattern of oligodendrocyte death, which 
progresses from the soma toward the myelin sheaths, is likely 
relevant for several insults, including viral infection, genetic de-
fects (e.g., lysosomal storage diseases), ischemia, and also a 
subgroup of MS patients (Rodriguez, 1992; Rodriguez and 
Scheithauer, 1994; Lucchinetti et al., 2000).
However, in the majority of MS patients, the damage is 
thought to occur at the level of the myelin sheath and to spread 
centripetally or “outside in.” When considering an autoimmune 
attack on myelin, we need to distinguish the different subcom-
partments that exist on the surface of a myelin sheath and hence 
can be targeted. The largest fraction of the myelin sheath sur-
face is tightly connected to the underlying myelin membrane 
stack, is lipid rich, and contains only very few surface proteins, 
among which the proteolipid protein and myelin-oligodendro-
cyte glycoprotein are the most abundant. These proteins are 
obvious targets for autoantibodies, and indeed, high levels of 
antibodies to myelin-oligodendrocyte glycoprotein have been 
described in pediatric cases of autoimmune demyelination, both 
in acute disseminated encephalomyelitis and in MS (Pröbstel 
et al., 2011). The noncompacted regions of myelin comprise 
the outer “tongue” (or “lip”) of the myelin membrane and the 
paranodal loops at the edges of each myelin internode. These 
areas are protein rich and composed of an entirely different set 
of proteins than compacted myelin, some of which are specifi-
cally targeted in autoimmune diseases. An interesting finding in 
this respect is the identification of autoantibodies in MS against 
neurofascin, a protein concentrated at the paranodes and at the 
node of Ranvier (Mathey et al., 2007). Furthermore, contactin-2/
TAG-1, a protein localized at the juxtaparanodal domain, has 
recently also been identified as an MS autoantigen targeted by 
T cells and autoantibodies (Derfuss et al., 2009). Interestingly, 
disintegration of the axon and glial connections at the paranodal 
junction is also observed after mild ischemia in mice (Reimer 
et al., 2011). It is possible that the myelin sheath is under par-
ticularly high tension at the paranodes, which may explain why 
this is a site of preferential damage.
A common structural feature of myelin in demyelinating 
diseases is the fragmentation of the membrane stacks. How is 
myelin membrane architecture distorted in diseases? Recently, 
we provided evidence that the interaction of myelin basic protein 
(MBP) with the cytoplasmic leaflet of the myelin bilayer triggers 
polymerization of MBP into a fibrous network that holds myelin 
lamellae together (Aggarwal et al., 2013). A transition of MBP 
back from a condensed to a dispersed phase may therefore trig-
ger acute myelin disassembly. This could, for example, occur by 
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consequences also occur if the sequence of damage is reversed 
is currently less well understood. However, an interesting exam-
ple of how damage signals could be transferred from neurons to 
glia comes from the PNS. Here, it has been shown that Schwann 
cells “sense” axon damage and respond by activating multi-
ple signaling pathways, including extracellular signal–regulated 
kinase–MAPK, JNK–c-Jun, Notch, and JAK-STAT (Janus 
kinase–signal transducers and activators of transcription; Harris-
ingh et al., 2004; Arthur-Farraj et al., 2006; Napoli et al., 2012). 
These signals not only induce cell activation but also trigger 
myelin fragmentation into ovoid structures in an active process 
that requires actin polymerization in the cytoplasmic clefts 
(so-called Schmidt–Lanterman incisures; Jung et al., 2011). 
Hence, at least in the PNS, it appears that once a destructive 
pathway is induced in one cell, this signal can be transferred to 
the other to orchestrate a mutual breakdown. Whether glial and 
neuronal fates are similarly coupled in the CNS remains to be 
explored. However, one may suspect that the consequences of 
cell loss on one side of the axon–myelin divide should be more 
variable in the CNS than in the PNS, as they likely depend on 
the specific stoichiometry of the axon–oligodendrocyte relation 
that varies in different parts of the brain and spinal cord.
Outlook: Spreading as a consequence of 
axon–myelin interdependence
So how do the mechanisms that mediate axon degeneration and 
myelin loss intersect? Can some of the mechanistic concepts 
that have emerged on one side of the axon–myelin unit be trans-
ferred to other? Interestingly, despite the clearly distinct roles of 
neurons and oligodendrocytes, both cell types display structural 
similarities. Both cell bodies need to support disproportionately 
large peripheral compartments—axons and synapses in the case 
of neurons and myelin sheaths in the case of the oligodendro-
cyte—via a relatively small and vulnerable-appearing set of 
conduits (Fig. 4). Both cells thus have to deal with the same 
challenge, namely how to best support their vast cellular periph-
ery from the soma. In neurons, fast and slow axonal transport 
processes that shuttle organelles and substrates between soma 
and synapses have evolved to meet this challenge (Hirokawa 
et al., 2010). It will be interesting to better understand the equiv-
alent transport processes in oligodendrocytes and along their 
myelin sheaths (Simons et al., 2012). Structural and functional 
similarities between axons and the oligodendrocyte also sug-
gest that shared mechanisms might mediate the removal of these 
cells or their degenerating appendages. Disturbances in organ-
elle transport have, for example, not only been linked to dying-
back neuropathies but also to the induction of active axonal 
self-destruction during Wallerian degeneration (Coleman et al., 
2005). Although some evidence already suggests the presence 
of a dying-back pathology in oligodendrocytes (Rodriguez, 
1992; Aboul-Enein et al., 2003), it is currently unclear whether 
active programs exist that could mediate dismantling of oligo-
dendrocyte processes. Likewise, it is interesting to speculate 
whether the stereotypic pruning of axonal connections during 
development leads to a similarly stereotypic removal of myelin 
sheaths that supported these early connections—a notion that 
seems at least possible, as transient myelination events have 
activation of Ca2+-dependent degradation pathways (Fig. 3). Al-
though the increased energy demand of an axon per se may not 
be sufficient to trigger axonal degeneration, it is likely that en-
ergy deprivation renders the neurons more vulnerable to stress. 
A “second hit”—for example, the induction of mitochondrial 
damage by reactive nitrogen and oxygen species or other inflam-
matory mediators—would exacerbate the energy mismatch and 
could be sufficient to induce axonal degeneration.
In addition to increased energy demand, demyelination 
likely also leads to the loss of trophic and metabolic support of 
the axon (Fig. 3). Indeed, myelin is not simply an inert insulator 
but contains metabolically active noncompacted regions. In this 
context, it is interesting that there are several mouse mutants that 
have minimal pathology within compacted regions of myelin but 
show disturbed organization of cytoplasm-rich areas. One exam-
ple is 2,3-cyclic nucleotide 3-phosphodiesterase 1–deficient 
mice, which show normal myelination by itself but have pathol-
ogy in noncompacted myelin compartments at the paranodal do-
mains (Lappe-Siefke et al., 2003; Rasband et al., 2005). Whereas 
the structural changes in the compacted myelin remain small, 
these mice develop a swelling of the inner tongue (Edgar et al., 
2009) and late-onset, chronic progressive neurodegeneration 
(Lappe-Siefke et al., 2003). Axonal swellings, transections, and 
an impairment of axonal transport that occur in these mice are 
highly reminiscent of the changes found in the CNS of pa-
tients suffering from MS. Such mouse mutants indicate that 
oligodendrocyte-derived metabolic support is required for axonal 
homeostasis. Indeed, recent data suggest that oligodendrocytes 
and axons are metabolically coupled and that oligodendrocytes 
provide lactate via MCT1 (monocarboxylate transporter 1) into 
the periaxonal space (Fünfschilling et al., 2012; Lee et al., 2012). 
Disruption of this mechanism by deletion of MCT1 causes neu-
rodegeneration. Although loss of metabolic support is an attrac-
tive hypothesis to explain how pathology may spread from glia 
to the axons, it is unlikely to be the only mechanisms. Gain of 
toxic function provides an additional explanation (Fig. 3). How-
ever, currently, it is mostly unknown which prodegenerative sig-
nals might be transferred from glia to neurons and how they act. 
There are a few exceptions: For example, psychosine is a cyto-
toxic sphingolipid that is generated in oligodendrocytes during 
globoid cell leukodystrophy (Krabbe’s disease) and spreads into 
axons where it causes damage (Cantuti Castelvetri et al., 2013). 
Other neurotoxic lipid species are acylcarnitines, intermediates 
of fatty acid -oxidation, which are generated in Schwann cells 
after mitochondrial dysfunction (Viader et al., 2013). Further-
more, dying oligodendrocytes are a major source of iron, which 
can exert toxicity if Fe2+ is oxidized by hydrogen peroxide to 
Fe2+ (Fenton reaction) and neurotoxic reactive hydroxyl radicals 
and hydroxyl anions are generated (Hametner et al., 2013). This 
mechanism might be of particular importance in advanced stages 
of MS, in which accumulating iron can amplify oxidative stress 
and contribute to progressive neurodegeneration.
In summary, myelin damage has severe consequences for 
the axonal partner that go beyond the loss of a protective insula-
tion and likely include an increased energy demand and lack of 
metabolic and trophic support as well as the exposure to myelin-
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axons that enter gray matter areas, for example, in the superfi-
cial layers of cortex, could transfer pathology from the white to 
the gray matter. Wallerian degeneration would be a classical ex-
ample of such a longitudinal spreading mechanism, and indeed, 
a recent histopathological study indicates that (at least part) of 
the widespread microglial activation that is found in progressive 
stages of MS is related to the phagocytosis of axonal and glial 
debris that results from Wallerian degeneration of axons (Singh 
et al., 2013). If the primary insult targets oligodendrocytes, this 
would likely impede the function of several axons (≤80 in the 
CNS; Chong et al., 2012) that are myelinated by the same oligo-
dendrocyte. Pathology would in this case spread in a more trans-
versal pattern (Fig. 5). In contrast to the longitudinal spread, this 
pattern would only be found in the CNS, as a result of the one-to- 
one relation of axons and myelinating Schwann cells in the PNS. 
Despite the very different points of initiation, both spreading modes 
could ultimately result in rather similar and diffuse patterns 
of axon–myelin damage. The degree to which this happens 
been observed (Berthold and Nilsson, 2002; Czopka et al., 
2013; Liu et al., 2013) and myelin can in rare cases be found 
around axon branches destined for elimination.
The interdependence of neuronal and glial health should 
also have major consequences for the way pathology spreads 
through the nervous system. Depending on the location of the 
primary insult, pathology could either originate in oligodendro-
cytes and extend to axons or advance in reverse direction. In this 
context, it is interesting to consider how the special geometry 
and stoichiometry of the axon–oligodendrocyte interaction may 
affect the pattern in which pathology spreads (Fig. 5). If the pri-
mary insult targets an axon, pathology may spread to the myelin 
sheaths covering the axon and further to the oligodendrocyte 
soma. As one oligodendrocyte is connected to several axons, 
a focal trigger may initiate a chain reaction within the entire nerve 
tract. Such a longitudinal spread of pathology along one axonal tract 
could, for example, explain how alterations progress from the 
brain to the spinal cord or vice versa. Moreover, myelinated 
Figure 3. Mechanisms of coupling injury within the axon–myelin unit. (A–C) Proposed mechanisms of injury that affect the axon–myelin unit involve 
several nonexclusive scenarios, including loss of trophic or metabolic support (A), increased energy demand as a result of loss of myelin or compromised 
membranes (B), and gain of toxic functions, either within the axon or emanating from the myelin (C). P, phosphorylation.
Figure 4. Topologic similarities between neu-
rons and oligodendrocytes. (A and B) As ex-
tended, process-bearing cells, neurons (A) and 
oligodendrocytes (B) show similarities in their 
topology, including a trophic center, the soma, 
which is connected with a metabolically highly 
active periphery (dark red; synapses for neu-
rons and the inner myelin tongue for oligoden-
drocytes) through a rather thin and vulnerable 
conduit (a neuron’s axon and oligodendro-
cytic processes, respectively). Oligodendrocytes 
carry a large additional membrane compart-
ment, compacted myelin (teal)—which in the 
main drawing is shown in a hypothetical “un-
rolled” state and also schematized in the cross 
section. Arrowheads point to the axon (A) and 
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Signal propagation along glial or neuroglial networks is likely to 
be further influenced by microglia cells that rapidly react to ner-
vous system pathology (Davalos et al., 2005) and that, as a result 
of their pleiotropic functions (Nayak et al., 2014), might both 
accelerate or limit the spread of neuroglial pathology, depending 
on the disease context (Miron et al., 2013).
Overall, the interdependence of the cellular partners of the 
axon–myelin unit has the potential to explain how pathological 
alterations can expand through the nervous system and across 
gray and white matter boundaries. The spreading hypothesis might 
thus help to understand how, in a disease such as MS, focal lesions 
present in the early relapsing-remitting stage of the disease can, 
over time, lead to widespread gray and white matter changes 
that characterize the advanced stages of the disease (Lassmann 
et al., 2012). It should be noted, however, that transition of a 
focal or multifocal to a diffuse disease process likely requires a 
disease-specific susceptibility of the axon–myelin unit or multi-
ple rounds of damage, as it is not observed after typical focal 
and isolated insults are caused, e.g., by trauma or ischemia. Here, 
the preexisting damage of the axon–myelin unit in MS that can 
result from the long-standing inflammatory process might play 
a key role. Spreading of pathology along the axon–myelin unit, 
however, is likely not exclusive to MS but might also contribute 
to the dissemination of pathology in classical neurodegenera-
tive diseases, such as Alzheimer’s disease, in which myelin 
damage has been observed both in patients with mild cognitive 
impairment and late-onset Alzheimer’s disease (Bartzokis, 2011; 
Carmeli et al., 2013).
Clearly, further work is necessary to reveal the signals that 
mediate communication, metabolic exchange, and structural in-
tegrity in the axon–myelin unit. With additional insights into the 
specific vulnerability of the axon–myelin unit, we will hope-
fully better understand how distinct signaling disturbances can 
result in characteristic patterns of neuroglia damage and pathol-
ogy progression in various CNS disorders.
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